Beta-Amyloid (1-38)

Aβ1-38 is a naturally occurring C-terminal amyloid-beta variant that is shorter than Aβ1-40 and Aβ1-42. Comparing these C-terminal variants helps define how peptide length influences aggregation and biomarker profiles.

• amyloid-beta aggregation research
• Alzheimer disease research
• sequence/control studies
• biochemical assay development

Exact fragment boundaries, sequence order and N-terminal chemistry can materially alter Aβ solubility, aggregation and recognition. Treat this construct as a distinct reagent and use matched controls.

1. Relative abundance of Alzheimer Aβ amyloid peptide variants in Alzheimer disease and normal aging